Evidence map›Paper›PMID 21464124›Full record

ArticleThe Journal of biological chemistry2011

The adaptor-associated kinase 1, AAK1, is a positive regulator of the Notch pathway.

Neetu Gupta-Rossi, Sara Ortica, Vannary Meas-Yedid, Sara Heuss, Julien Moretti, Jean-Christophe Olivo-Marin, Alain Israël

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. eLife · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. TNIK signaling imprints CD8Nature communications · 2020
    Article
  11. SGC-AAK1-1: A Chemical Probe Targeting AAK1 and BMP2K.ACS medicinal chemistry letters · 2020
    Article
  12. Serine/Threonine Protein Kinase STK16.International journal of molecular sciences · 2019
    Review
  13. Article
  14. Article
  15. Viral journeys on the intracellular highways.Cellular and molecular life sciences : CMLS · 2018
    Review
  16. Article
  17. Article
  18. Article
  19. Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain.The Journal of pharmacology and experimental therapeutics · 2016
    Article
  20. Immune signatures and disorder-specific patterns in a cross-disorder gene expression analysis.The British journal of psychiatry : the journal of mental science · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Neetu Gupta-RossiUnité de Signalisation Moléculaire et Activation Cellulaire, CNRS URA 2582, CNRS URA 2582, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex 15, France. neetu.gupta@pasteur.fr
Sara Ortica
Vannary Meas-Yedid
Sara Heuss
Julien Moretti
Jean-Christophe Olivo-Marin
Alain Israël
Biotechnologie et Signalisation Cellulaire · FRCentre National de la Recherche Scientifique · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Notch pathway is involved in cell-cell signaling during development and adulthood from invertebrates to higher eukaryotes. Activation of the Notch receptor by its ligands relies upon a multi-step processing. The extracellular part of the receptor is removed by a metalloprotease of the ADAM family and the remaining fragment is cleaved within its transmembrane domain by a presenilin-dependent γ-secretase activity. γ-Secretase processing of Notch has been shown to depend upon monoubiquitination as well as clathrin-mediated endocytosis (CME). We show here that AAK1, the adaptor-associated kinase 1, directly interacts with the membrane-tethered active form of Notch released by metalloprotease cleavage. Active AAK1 acts upstream of the γ-secretase cleavage by stabilizing both the membrane-tethered activated form of Notch and its monoubiquitinated counterpart. We propose that AAK1 acts as an adaptor for Notch interaction with components of the clathrin-mediated pathway such as Eps15b. Moreover, transfected AAK1 increases the localization of activated Notch to Rab5-positive endocytic vesicles, while AAK1 depletion or overexpression of Numb, an inhibitor of the pathway, interferes with this localization. These results suggest that after ligand-induced activation of Notch, the membrane-tethered form can be directed to different endocytic pathways leading to distinct fates.

Indexed as

Adaptor Proteins, Signal TransducingAmyloid Precursor Protein SecretasesCalcium-Binding ProteinsCell MembraneEndocytosisHEK293 CellsHeLa CellsHumansIntracellular Signaling Peptides and ProteinsMembrane ProteinsMetalloproteasesNerve Tissue ProteinsPhosphoproteinsProtein Serine-Threonine KinasesProtein Stabilityrab5 GTP-Binding ProteinsAAK1 protein, humanAdaptor Proteins, Signal TransducingAmyloid Precursor Protein SecretasesCalcium-Binding ProteinsEPS15 protein, humanIntracellular Signaling Peptides and ProteinsMembrane ProteinsMetalloproteasesNerve Tissue ProteinsNUMB protein, humanPhosphoproteinsProtein Serine-Threonine Kinasesrab5 GTP-Binding ProteinsReceptors, Notch

Identifiers

PMID21464124
PMCPMC3099689
OpenAlexW1971882415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.